References
- AdelrothERakSHaahtelaTRecombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitisJ Allergy Clin Immunol2001106253910932067
- ALTANA PharmaCiclesonide nasal sprayDraft Labeling Text 1.14.1.32006
- AnderssonPRyrfeldtABiotransformation of the topical glucorticosteroids budesonide and beclomethasone 17,21 dipropionate in human liver and lung homogenateJ Pharm Pharmacol198476376536
- AnderssonMSvenssonCPerssonCDose-dependent effects of budesonide aqueous nasal spray on symptoms in daily nasal allergen challenge modelAnn Allergy Asthma Immunol200027928385
- [ARIA] Allergic Rhinitis and its Impact on Asthma guidelines2007 Accessed 31 Jan 2008. URL: http://www.whiar.org/
- BarnesPJAdcockIAnti-inflammatory actions of steroids: molecular mechanismTrends Pharmacol Sci199343644114
- BarnesPJInhaled glucocorticoids for asthmaN Engl J Med1995332868757870143
- BarnesPJMolecular mechanism of steroid action in asthmaJ Allergy Clin Immunol199615916897
- BavbekSKumbasarHTugcuHPsychological status of patients with seasonal and perennial allergic rhinitisJ Investig Allergol Clin Immunol20021220410
- BeckLAMarcotteGVMacGlashanDOmalizumab-induced reductions in mast cell Fcepsilon RI expression and functionJ Allergy Clin Immunol20041145273015356552
- BergerWENayakASStaudingerHWMometasone furoate improves congestion in patients with moderate to-severe seasonal allergic rhinitisAnn Pharmacother2005391984916278257
- BergerWGuptaNMcAlaryMEvaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthmaAnn Allergy Asthma Immunol200391182812952113
- BerkowitzRBRobersonSZoraJMometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure settingAllergy Asthma Proc1999a16717220.a
- BerkowitzRBBernsteinDILaForceCOnset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitisAllergy1999b646954.b
- BernsteinILIs the use of benzalkonium chloride as a preservative fornasal formulations a safety concern? A cautionary note based on compromisedmucociliary transportJ Allergy Clin Immunol2000105394410629450
- BernsteinDILevyALHampelFCTreatment with intranasal fluticasone propionate significantly improves ocular symptoms in patients with seasonal allergic rhinitisClin Exp Allergy200434952715196285
- BezCSchubertRKoppMEffect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitisClin Exp Allergy20043410798515248853
- BhatiaSBaroodyFMdeTineoMIncreased nasal airflow with budesonide compared with desloratadine during the allergy seasonArch Otolaryngol Head Neck Surg2005131223815781762
- BronskyEAAaronsonDWBerkowitzRBDose ranging study of mometasone furoate (nasonex) in seasonal allergic rhinitisAnn Allergy Asthma Immunol1997515679
- BrownPHBlundellGGreeningAPDO large volume spacer device reduce the systemic effects of hight dose inhaled corticosteroids?Thorax199073673995
- Carson-JuricaMASchraderWTO’MalleyBWSteroid receptor family: structure and functionEndocr Rev199020121011
- ChervinskyPCasaleTTownleyROmalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitisAnn Allergy Asthma Immunol200391160712952110
- CreticosPFiremanPSettipaneGIntranasal budesonide aqueous pump spray (Rhinocort aqua) for the treatment of seasonal allergic rhinitis. Rhinocort Aqua Study GroupAllergy Asthma Proc199828529419
- CuffelBWamboldtMBorishLEconomic consequences of comorbid depression, anxiety, and allergic rhinitisPsychosomatics199940491610581977
- DayJHBriscoeMPRateiroEOnset of action of intranasal budesonide (Rhinocort Aqua) in seasonal allergic rhinitis studied in a controlled exposure modelJ Allergy Clin Immunol200010534899410719298
- DayJHBriscoeMPRateiroEA single-dose of budesonide 64 μg (Rhinocort Aqua) is effective for severe allergic rhinitis symptoms in a controlled pollen settingJ Allergy Clin Immunol2001S313107
- DietzelKENgelstatterRKellerACiclesonide: an on site- activated steroidProg Respir Res200131913
- DolovichJWongAGChodirkerWBMulticenter trial of fluticasone propionate aqueous nasal spray in ragweed allergic rhinitisAnn Allergy199414715373
- DupclayLJrDoyleJAssessment of intranasal corticosteroid use in allergic rhinitis: Benefits, costa, and patient preferencesAm J Manag Care2002S335S3408
- DykewiczMSKaiserHBNathanRAFluticasone proprionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as neededAnn Allergy Asthma Immunol2003414891
- EnglishAFNeateMSQuintDJBiological activities of some steroids used in asthmaAm J Respir Crit Care Med1994Suppl 4A212149
- ForesiAPelucchiAGhersonGOnce daily intranasal fluticasone propinate (200 micrograms) reduces nasal symptoms and inflammation but also attenuates the increase in bronchial responsiveness during the pollen season in allergic rhinitisJ Allergy Clin Immunol1996982274828757203
- FunderJWMineralcorticosteroids, glucocorticosteroids, receptors and response elementsScience199311321136259
- GawchikSGoldsteinSPrennerBRelief of cough and nasal symptoms associated with allergic rhinitis by mometasone furoate nasal sprayAnn Allergy Asthma Immunol200341642190
- Gerth Van WijkRQuality of life, should we bother?Allergy200358284612708973
- GrafPAdverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosaClin Ther19992117495510566570
- HanfGNogaOO’ConnorAOmalizumab inhibits allergen challenge-induced nasal responseEur Respir J200423414815065831
- HermanHOne-daily administration of intranasal corticosteroids for allergic rhinitis: A comparative review of efficacy, safety, patient preference, and costAm J Rhinol2007707921
- HolgateSCasaleTWenzelSThe anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammationJ Allergy Clin Immunol20051154596515753888
- JohnsonMPharmacodynamics and pharmacokinetics of inhaled glucocorticoidsJ Allergy Clin Immunol199616917697
- KalinerMAOmalizumab and the treatment of allergic rhinitisCurr Allergy Asthma Rep200442374415056407
- KirmazCAydemirOBayrakPSexual dysfunction in patients with allergic rhinoconjunctivitisAnn Allergy Asthma Immunol200595525916400890
- KraftMDjukanovicMWilsonRAlveolar tissue inflammation in asthmaAm J Respir Crit Care Med199615051510154
- KremerBden HartogHMJollesJRelationship between allergic rhinitis, disturbed cognitive functions and psychological well-beingClin Exp Allergy2002321310512220469
- LaForceCFDockhornRJFindlaySRFluticasone prorpionate: an effective alternative treatment for seasonal allergic rhinitis in adults and adolescentsJ Fam Pract199414515238
- LaitinenALaitinenLAArway morphology:epithelium/basement membraneAm J Respir Crit Care Med1994S14S17150
- LeongKPYeakSCSaurajenASWhy generic and disease-specific quality of-life instruments should be used together for the evaluation of patients with persistent allergic rhinitisClin Exp Allergy2005352889815784105
- LipworthBJNew prospectives on inhaled drug delivery and systemic bioactivityThorax199510511010
- LindgrenSBakeBLarssonSClinical consequences of inadequate inhalation technique in asthma therapyEur J Respir Dis1987709383817076
- LinnaOKokkonenJLukinMA 10-year prognosis for childhood allergic rhinitisActa Paediatr19928110021515750
- MarshallPSO’HaraCSteinbergPEffects of seasonal allergic rhinitis on selected cognitive abilitiesAnn Allergy Asthma Immunol2000844031010795648
- MarshallPSO’HaraCSteinbergPEffects of seasonal allergic rhinitis on fatigue levels and moodPsychosom Med2002646849112140359
- MeltzerEOQuality of life in adults and children with allergic rhinitisJ Allergy Clin Immunol20011081 SupplS455311449206
- MeltzerEODerendorfHThe systemic safety of inhaleted corticosteroid therapy: a focus on ciclesonideAnn Allergy Asthma Immunol2006971495716937743
- MeltzerEOKunjibettuSHallNEfficay and safety of ciclesonide, 200 μg once daily, for the treatment of perennial allergic rhinitisAnn Allergy Asthma Immunol200717518198
- Miller-LarsonAMattsonHOhlssonDProlonged release from the arway tissue of glucocorticoids budesonide and fluticasone prrpionate as compared to beclomethasone dipropionate and hydrocortisoneAm J Respir Crit Care Med1994A466148
- MunchEPTaudorfEWeekeBDose frequency in the treatment of asthmatics with inhaled topical steroidEur J Respir Dis198212214353
- MunkAMendelDBSmithLIGlucocorticoid receptor and actionAm Rev Respir Dis1990S2S10141
- MunkZMLaForceCFurstJAEfficacy and safety of triamcinolone acetonide aqueous nasal spray in patients with seasonal allergic rhinitisAnn Allergy Asthma Immunol199627728177
- Nasonex (mometasone furoate monohydrate)2003Kenilworth (NJ)Schering Corp [package insert]
- NathanRABronskyEAFiremanPOnce daily fluticasone propionate aqueous nasal spray is an effective treatment for seasonal allergic rhinitisAnn Allergy199133233867
- NaveRMeyerWFuhstRFormation of fatty acid conjiugates of ciclesonide active metabolite in the rat lung after4 week inhalation of ciclesonidePulm Pharmacol Ther200539039618
- NaveRWingertzahnMABrookmanSSafety, tolerability, and exposure of Ciclesonide nasal spray in healthy and asymptomatic subjets with seasonal allergic rhinitisJ Clin Pharmacol200646146746
- NayakACasaleTMillerSDTolerability of retreatment with omalizumab, a recombinant humanized monoclonal anti-IgE antibody, during a second ragweed pollen season in patients with seasonal allergic rhinitisAllergy Asthma Proc200324323914619332
- NewmanSPWeiszAWBTalaeeNImprovement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler techniqueThorax199171271646
- PassalacquaGAlbanoMCanonicaGWInhaled and nasal corticosteroids: safety aspectsAllergy2000163355
- PedersenSFrostLArnfredTErrors in inhalation technique and effciency in inhaler use in asthmatic childrenAllergy198611812341
- PedersenSInhalers and nebulisers: which to choose and whyRespir Med1996697790
- PincusDJSzetlerSJAckersonLNChronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efÆcacyJ Allergy Clin Immunol19951172117895
- PlewakoHArvidssonMPetrusonKThe effect of omalizumab on nasal allergic inflammationJ Allergy Clin Immunol2002110687112110823
- RatnerPHvan BavelJHHampelFDose dependent effectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitis (SAR)J Allergy Clin Immunol2004S28113 Abstract
- RatnerPHWingertzahnMAVan BavelJHEffectiveness of ciclesonide nasal spray in the treatment of seasonal allergic rhinitisAnn Allergy Asthma Immunol2006a657663.a97
- RatnerPHWingertzahnMAvan BavelJHEfficacy and safety of ciclesonide nasal spray for the treatment of seasonal allergic rhinitisJ Allergy Clin Immunol2006b1181142817088141
- SalmunLMLorberR24-hour efficacy of once-daily desloratadine therapy in patients with seasonal allergic rhinitisBMC Fam Pract200231412162793
- SchmidtBMTimmerWGeorgensACThe new topical steroid ciclesonide is effective in the treatment of allergic rhinitisJ Clinical Pharmacol19991062106939
- SelroosOHalmeMEffect of a volumatic spacer and mouth rinsing on systemic absorption of inhaled corticosteroids from a metered dose inhaler and dry powder inhalerThorax199189189446
- SettipaneGKorenblatPEWinderJTriamcinolone acetonide aqueous nasal spray in patients with seasonal ragweed allergic rhinitis: A placebo – controlled, double blind studyClin Ther19952522632
- SmithDFToftDOSteroid receptor and their associated proteinsMol Endocrinol19934107
- SmithECDenyerJKendrickAHComparison of twenty-three nebulizer/compressor combinations for domiciliary useEur Respir J1995121412218
- ToogoodJHBaskervilleJJenningsBUse of spacers to facilitate inhaled corticosteroid treatment of asthmaAm Rev Respir Dis1984723729129
- UkenaDCiclesonidePneumologie2005596899516222581
- van SchayckCPvan Den BroekPJJvan Den OtterJJPeriodic treatment regimen with inhaled steroids in asthma or chronic obstructive pulmonary diseaseJAMA1995161164274
- WingertzahmMSatoHNaveRUptake and activation of Ciclesonide (CIC) in hypotonic and isotonic suspension and the formation of fatty acid conjiugates of desisobutyryl-ciclesonide (des-CIC) in vivo in rabbit nasal mucosa2005Paper presented at 23rd Annual Aspen Allergy ConferenceJuly 26–30Aspen. Colorado